Clinical Trial Update: Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial investigating probiotics to reduce adverse effects and dysbiosis during Helicobacter pylori eradication therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN